Treatment after progression on osimertinib is reviewed; repeat molecular testing and liquid biopsy are discussed. For more resources and information regarding anticancer targeted therapies: targetedonc.com/
This was a ray of light. Are there any pointers for additional information on clinical trials in progress for this topic? Also, I'm wondering if there is a name with the physician presenting. His clear and concise discussion was terrific!
